M B Loughrey

Summary

Affiliation: Northern Ireland
Country: UK

Publications

  1. ncbi request reprint Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer
    M B Loughrey
    Molecular Pathology Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Vic, Australia
    Fam Cancer 6:301-10. 2007
  2. pmc BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1 tumour phenotype
    Cameron Snell
    Molecular Pathology Research and Development Laboratory, Department of Pathology, Peter MacCallum Cancer Centre, Locked Bag 1, A Beckett St, Melbourne, Victoria 8006, Australia
    Breast Cancer Res 10:R12. 2008
  3. ncbi request reprint KIT immunohistochemistry and mutation status in gastrointestinal stromal tumours (GISTs) evaluated for treatment with imatinib
    M B Loughrey
    Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia
    Histopathology 49:52-65. 2006
  4. pmc Gastrointestinal stromal tumour treated with neoadjuvant imatinib
    M B Loughrey
    Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC 3002, Australia
    J Clin Pathol 58:779-81. 2005
  5. ncbi request reprint Pathological response of gastrointestinal stromal tumour to imatinib treatment correlates with tumour KIT mutational status in individual tumour clones
    M B Loughrey
    Histopathology 49:99-100. 2006

Collaborators

Detail Information

Publications5

  1. ncbi request reprint Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer
    M B Loughrey
    Molecular Pathology Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Vic, Australia
    Fam Cancer 6:301-10. 2007
    ....
  2. pmc BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1 tumour phenotype
    Cameron Snell
    Molecular Pathology Research and Development Laboratory, Department of Pathology, Peter MacCallum Cancer Centre, Locked Bag 1, A Beckett St, Melbourne, Victoria 8006, Australia
    Breast Cancer Res 10:R12. 2008
    ..We hypothesised that inactivation of BRCA1 by promoter methylation could occur as a germline or an early somatic event that predisposes to breast cancer with the phenotype normally associated with BRCA1 germline mutation...
  3. ncbi request reprint KIT immunohistochemistry and mutation status in gastrointestinal stromal tumours (GISTs) evaluated for treatment with imatinib
    M B Loughrey
    Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia
    Histopathology 49:52-65. 2006
    ....
  4. pmc Gastrointestinal stromal tumour treated with neoadjuvant imatinib
    M B Loughrey
    Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC 3002, Australia
    J Clin Pathol 58:779-81. 2005
    ..The implications for this management option of radiological, pathological, and molecular assessment are discussed...
  5. ncbi request reprint Pathological response of gastrointestinal stromal tumour to imatinib treatment correlates with tumour KIT mutational status in individual tumour clones
    M B Loughrey
    Histopathology 49:99-100. 2006